Editor's Choice Survival outcomes in young adults with metastatic colorectal cancer vary by socioeconomic context January 18, 2026 A large cohort study published in JAMA Network Open has documented significant disparities in survival…
Editor's Choice Gut bacteria from tree frogs: unexplored biodiversity could represent a treasure trove for novel medical technology December 26, 2025 A research team of Prof. Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST)…
Editor's Choice Valvular heart disease is common in cancer patients but interventions improve survival December 21, 2025 Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat…
Editor's Choice Keeping the heart healthy increases longevity even after cancer December 21, 2025 Being more physically active, following a balanced diet, not smoking, and keeping body weight and…
Editor's Choice New gene-mapping method unlocks hidden drivers of cancer December 14, 2025 University of South Australia scientists have developed a powerful new way to uncover the genetic…
ASH ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia December 14, 2025 A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College…
Editor's Choice Potential treatment to bypass resistance in neuroblastoma December 6, 2025 A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a…
Editor's Choice US public trust in scientists remains high — but political ideology shapes confidence in cancer information December 6, 2025 A new US survey suggests that while scientists remain highly trusted sources of cancer information,…
Editor's Choice Time is of the essence: the impact of precision oncology in Australia December 1, 2025 A new landmark report by Omico confirms precision oncology – the use of genomics to…
Editor's Choice Growing use of GLP-1 receptor agonists for obesity among patients with cancer raises need for evidence-based guidance December 1, 2025 A new research letter published in JAMA Oncology reports that semaglutide and tirzepatide—two widely used…